Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Forecast for the Whole Exome Sequencing Market from 2024 to 2025?

The entire exome sequencing market has seen swift growth in the recent past and this growth is set to continue. It is projected to rise from $2.82 billion in 2024 to $3.37 billion in 2025, with an impressive compound annual growth rate (CAGR) of 19.4%. This growth during the historical period has been fueled by advances in genomic research, the rising trend of precision medicine, the diagnosis of rare diseases, applications in the pharmaceutical and biotech industries, as well as the reduction in sequencing costs.

What Is the Projected Market Size of the Whole Exome Sequencing Market?

The market size for whole exome sequencing is anticipated to experience a significant surge in the coming years, expanding to “$7.29 billion by 2029 with a compound annual growth rate (CAGR) of 21.3%. This predicted growth over the forecast period is attributed to the increase in oncology applications, its incorporation in clinical diagnostics, a surge in the requirement for genetic testing, population genomics initiatives, and the rise of gene therapies. Key trends to look out for during the forecast period encompass enhanced clinical utilization and adoption, falling sequencing costs, emphasis on data security and confidentiality, merging with electronic health records, and progress in single-cell sequencing.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10669&type=smp

Who are the Major Competitors in the Whole Exome Sequencing Market Outlook?

Major companies operating in the whole exome sequencing market include Thermo Fisher Scientific Inc., Illumina Inc., Eurofins Genomics, Azenta US Inc., CD Genomics, Psomagen Inc., Agilent Technologies, BGI Genomics, F. Hoffmann-La Roche Ltd., QIAGEN Inc., Macrogen Inc., Ambry Genetics, Bio-Rad Laboratories Inc., Bioneer Corporation, Foundation Medicine Inc., KONICA MINOLTA INC., Otogenetics Corporation, Geneyx Genomex Ltd., ArcherDX Inc., Blueprint Genetics Oy, Bionano Genomics Inc., Centogene AG, Fulgent Genetics Inc., Natera Inc., GeneDx Inc., GENEWIZ Inc., Novogene Corporation, PerkinElmer Inc., Personalis Inc.

What Is Fueling Growth in the Whole Exome Sequencing Market?

The escalating prevalence of HIV (human immunodeficiency virus) is anticipated to stimulate the expansion of the whole exome sequencing market in the future. HIV is a virus that attacks the body’s immune system. Whole exome sequencing is adopted to reveal genomic structures of viruses, valuable for personalized therapies and vaccine schemes for HIV. For example, in August 2024, the US-based government agency, the Minority HIV/AIDS Fund (MHAF), estimated that about 39.9 million people across the globe were living with HIV in 2023, including 1.4 million children and 38.6 million adults, showing an increase from previous years. Therefore, the rising prevalence of HIV is fuelling the growth of the whole exome sequencing market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=10669&type=smp

Which Whole Exome Sequencing Market Segments Are Growing the Fastest?

The whole exome sequencing market covered in this report is segmented –

1) By Product: Systems, Kits, Services

2) By Technology: Sequencing By Synthesis, Ion Semiconductor Sequencing, Other Technologies

3) By Application: Diagnostics, Drug Discovery And Development, Personalized Medicine, Agriculture And Animal Research

4) By End-User: Hospitals And Clinics, Pharmaceutical And Biotechnology Companies, Academic and Research Institutes, Clinical Laboratories, Other End-Users

Subsegments:

1) By Systems: Sequencing Systems, Data Analysis Systems

2) By Kits: Library Preparation Kits, Exome Enrichment Kits, Sequencing Kits

3) By Services: Data Analysis Services, Consulting Services, Custom Sequencing Services

Which Industry Trends Are Shaping the Future of the Whole Exome Sequencing Market?

Emerging diagnostic advances appear as a key trend gaining traction in the entire market for exome sequencing. Corporations active within this area are innovating new products to maintain their competitive edge. For instance, Illumina Inc., an American biotech firm, introduced NovaSeqX Plus in February 2023, which represents the pinnacle of sequencing technology, offering an unmatched blend of high throughput, accuracy, and sustainable and economical sequencing advancements. The improvements incorporated into the NovaSeq X Plus systems are capable of producing tens of thousands of whole genomes annually, optimising productivity and minimizing turnaround time.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/whole-exome-sequencing-global-market-report

Which Countries Are Leading the Whole Exome Sequencing Market?

North America was the largest region in the whole exome sequencing market in 2024.Asia-Pacific is expected to be the fastest-growing region in the global whole exome sequencing market report during the forecast period. The regions covered in the whole exome sequencing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10669

This Report Delivers Insight On:

1. How big is the whole exome sequencing market, and how is it changing globally?

2. Who are the major companies in the whole exome sequencing market, and how are they performing?

3. What are the key opportunities and risks in the whole exome sequencing market right now?

4. Which products or customer segments are growing the most in the whole exome sequencing market?

5. What factors are helping or slowing down the growth of the whole exome sequencing market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model